Leo I Gordon

31PUBLICATIONS
101CO-AUTHORS
Applied statisticsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursAutoimmunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jun 04, 2026
Five-year survival outcomes from TRANSCEND NHL 001 of lisocabtagene maraleucel in R/R LBCL.

|Nov 07, 2025
Outcomes for CART as 2L vs 3L vs 4L or beyond in aggressive B-cell lymphoma: real-world evidence from the ABC Consortium.

John S Wang, Brandon L Ellsworth, Megan Melody

|Oct 22, 2025
Outcomes of bispecific antibodies after CAR T-cell failure for large B-cell lymphoma: results from the ABC consortium.

Megan Melody, Natalie Grover, Stephanie Franco

|Jul 29, 2025
Real World Outcomes of Patients with Aggressive Lymphoma and Autoimmune Disease Treated with CART.

Nicole J Altomare, Megan M Herr, Nisha M Nair

|Jul 24, 2025
Nivolumab in combination with R-CHOP for treatment-naïve diffuse large B-cell lymphoma: an evaluation of safety and efficacy.

Oluwatobi Odetola, Shuo Ma, Jane Winter

|May 30, 2025
CRISPR screen reveals a simultaneous targeted mechanism to reduce cancer cell selenium and increase lipid oxidation to induce ferroptosis.

Sophia M Lamperis, Kaylin M McMahon, Andrea E Calvert

Pageof 6

Frequent Collaborators

16 joint publications

Reem Karmali

10 joint publications

Shuo Ma

7 joint publications

Thomas Ollila

7 joint publications

Narendranath Epperla